Cleared Traditional

K211233 - Hailie Sensor NF0109

K211233 is an FDA 510(k) clearance for Hailie Sensor NF0109, manufactured by Adherium (Nz), Ltd.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 117-day FDA review.

K211233 · Adherium (Nz), Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2021
Decision
117d
Days
Class 2
Risk

K211233 is an FDA 510(k) clearance for the Hailie Sensor NF0109. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Adherium (Nz), Ltd. (Auckland, NZ). The FDA issued a Cleared decision on August 18, 2021 after a review of 117 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Adherium (Nz), Ltd. devices

FDA 510(k) Submission Details - K211233

510(k) Number K211233 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 23, 2021
Decision Date August 18, 2021
Days to Decision 117 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
23d faster than avg
Panel avg: 140d · This submission: 117d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 196
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K211233.
Airvo Nebulizer Adapter
K211560 · Fisher & Paykel Healthcare Limited · Dec 2021
Sodium Chloride Inhalation Solutions, 3%, 3.5%, 7% and 10%
K210126 · The Ritedose Corporation · Dec 2021
BreatheSuite MDI V1
K203155 · Breathesuite, Inc. · Sep 2021
Nebulizer Kit
K192971 · Excellentcare Medical (Huizhou) , Ltd. · Jul 2021
Pulmogine Vibrating Mesh Nebulizer
K202171 · Hcmed Innovations Co., Ltd. · Jul 2021
Ultrasonic Mesh Nebulizer
K201397 · Shenzhen Ivankaca Technology Co., Ltd. · Jun 2021